Product Information

TOPIRAMATE ER 50 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $6.2684 per EA under NDC 00480235701. Its NADAC has been published 153 times since Jul 26, 2023.

TOPIRAMATE ER 50 MG CAPSULE

Topiramate
$6.2684per EA

Strength

50 mg/1

NDC

00480235701

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206210

On Market Since

5/3/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 50 MG CAPSULE has been published 153 times since Jul 26, 2023, and over the history we have for it it has declined 46.0%. The table below summarizes its recorded NADAC range and movement.

Current price$6.2684 per EA
All-time high$11.6059 (Aug 16, 2023)
All-time low$5.3769 (Nov 20, 2024)
52-week high$6.7514
52-week low$5.7954
Median price$6.9134
Average price$7.3880
Largest weekly change-28.1% (Feb 21, 2024)
Weeks tracked153
Tracking sinceJul 26, 2023

Price History

1W

0.0%

1M

-2.3%

3M

+8.2%

6M

-7.2%

1Y

+0.1%

3Y

N/A

5Y

N/A

All

-46.0%

Generic Alternatives

The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 50 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $6.2684 per EA (NDC 00480235701), effective Jun 24, 2026.

How has the price of TOPIRAMATE ER 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has declined 46.0%. It has been tracked across 153 weekly CMS publications since Jul 26, 2023.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 50 MG CAPSULE?

Since Jul 26, 2023, the NADAC for TOPIRAMATE ER 50 MG CAPSULE has ranged from a low of $5.3769 (Nov 20, 2024) to a high of $11.6059 (Aug 16, 2023), with a median of $6.9134 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 50 MG CAPSULE?

Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 50 MG TABLET, is $0.0345 per EA — about 99% below TOPIRAMATE ER 50 MG CAPSULE.

Who manufactures TOPIRAMATE ER 50 MG CAPSULE?

TOPIRAMATE ER 50 MG CAPSULE (NDC 00480235701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.